At Wellorithm, we believe that every patient deserves to feel confident and safe when managing their metabolic health
A subsequent study that followed 43 patients for up to four years found those with mild dementia or moderate-early dementia who took lipoic acid (600 mg/day), in addition to acetylcholinesterase inhibitors, experienced slower cognitive decline compared to the typical cognitive decline of Alzheimers patients as reported in the literature (102)
In fact, clinicians have reported numerous advantages using these new, advanced techniques: Changes in mucosal and vascular patterns can be identified which can predict histology indicative of dysplasia, resulting in a potentially improved ability to screen for Barretts Esophagus, detect dysplasia in established Barretts esophagus and detect recurrent dysplasia/neoplasia after ablation
It increases blood flow to damaged tissues, reduces local inflammation, and supports the formation of new collagen for stronger, healthier tissue
) 188 (Wiley-Blackwell, 2016)
